Literature DB >> 16412619

Application of TPGS in polymeric nanoparticulate drug delivery system.

L Mu1, P H Seow.   

Abstract

d-alpha-Tocopheryl polyethylene glycol 1000 succinate (TPGS) has great potential in pharmacology and nanotechnology. The present work investigated the molecular behaviour of TPGS at the air-water interface, its effect on a model bio-membrane composed of dipalmitoylphosphatidylcholine (DPPC) lipid monolayer, and the interaction between the TPGS coated nanoparticles with the lipid model membrane. Paclitaxel loaded polymeric nanoparticles with TPGS as surfactant stabiliser were fabricated and characterised in terms of their drug incorporation capability and release kinetics. The result showed that TPGS exhibited notable effect on the surface properties of air-water interface as well as the lipid monolayer. The inter-particle force and the interaction between nanoparticles and lipid monolayer varied with the surface substance. The penetration of various nanoparticles into the model membrane indicated that an optimal balance between hydrophilicity and hydrophobicity on nanoparticle surface is needed to achieve an effective cellular uptake of nanoparticles. The results also demonstrate that the drug incorporation capability and the release characteristics of drug-loaded nanoparticles can be influenced by surfactant stabiliser.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412619     DOI: 10.1016/j.colsurfb.2005.08.016

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  12 in total

Review 1.  Biopolymeric nanoparticles.

Authors:  Sushmitha Sundar; Joydip Kundu; Subhas C Kundu
Journal:  Sci Technol Adv Mater       Date:  2010-02-26       Impact factor: 8.090

2.  Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.

Authors:  Ping Ma; Russell J Mumper
Journal:  Nano Today       Date:  2013-06-01       Impact factor: 20.722

3.  Quercetin in lyotropic liquid crystalline formulations: physical, chemical and functional stability.

Authors:  Fabiana T M C Vicentini; Rúbia Casagrande; Waldiceu A Verri; Sandra R Georgetti; M Vitória L B Bentley; Maria J V Fonseca
Journal:  AAPS PharmSciTech       Date:  2008-05-03       Impact factor: 3.246

Review 4.  Biophysical interactions with model lipid membranes: applications in drug discovery and drug delivery.

Authors:  Chiranjeevi Peetla; Andrew Stine; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

5.  Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery.

Authors:  Qi Tan; Weidong Liu; Chenyu Guo; Guangxi Zhai
Journal:  Int J Nanomedicine       Date:  2011-08-10

6.  Preparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly(butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrate.

Authors:  Sarra Abbad; Cheng Wang; Ayman Yahia Waddad; Huixia Lv; Jianping Zhou
Journal:  Int J Nanomedicine       Date:  2015-01-06

7.  Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.

Authors:  Xiangju Zhao; Ying Sun; Zhaoguo Li
Journal:  Drug Des Devel Ther       Date:  2018-12-13       Impact factor: 4.162

Review 8.  Concepts and practices used to develop functional PLGA-based nanoparticulate systems.

Authors:  Hongkee Sah; Laura A Thoma; Hari R Desu; Edel Sah; George C Wood
Journal:  Int J Nanomedicine       Date:  2013-02-21

9.  Curcumin-Loaded PLA Nanoparticles: Formulation and Physical Evaluation.

Authors:  Heni Rachmawati; Yulia L Yanda; Annisa Rahma; Nobuyuki Mase
Journal:  Sci Pharm       Date:  2016-02-14

10.  A composite nanocarrier to inhibit precipitation of the weakly basic drug in the gastrointestinal tract.

Authors:  Chunli Zheng; Yun Li; Zhen Peng; Xinyi He; Juan Tao; Liang Ge; Yixin Sun; Yunkai Wu
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.